In a filing, Resmed Inc revealed its Officer Farrell Michael J. acquired Company’s shares for reported $2.02 million on Jun 09 ’25. In the deal valued at $252.00 per share,8,009 shares were bought.
Then, FARRELL PETER C sold 2,000 shares, generating $494,640 in total proceeds. Upon selling the shares at $247.32, the Director now owns 69,218 shares.
Before that, FARRELL PETER C bought 2,000 shares. Resmed Inc shares valued at $500,000 were divested by the Director at a price of $250.00 per share.
Morgan Stanley initiated its Resmed Inc [RMD] rating to an Overweight in a research note published on March 19, 2025; the price target was $280. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who began to cover the stock in mid March with a ‘”an Overweight”‘ rating. Goldman began covering RMD with “Buy” recommendation on January 16, 2025. Piper Sandler started covering the stock on January 10, 2025. It rated RMD as “a Neutral”.
Price Performance Review of RMD
On Monday, Resmed Inc [NYSE:RMD] saw its stock fall -0.48% to $250.98. Over the last five days, the stock has gained 2.85%. Resmed Inc shares have risen nearly 9.75% since the year began. Nevertheless, the stocks have risen 17.70% over the past one year. While a 52-week high of $263.05 was reached on 01/30/25, a 52-week low of $179.42 was recorded on 04/07/25. SMA at 50 days reached $233.67, while 200 days put it at $237.27.
Levels Of Support And Resistance For RMD Stock
The 24-hour chart illustrates a support level at 248.89, which if violated will result in even more drops to 246.81. On the upside, there is a resistance level at 252.74. A further resistance level may holdings at 254.51. The Relative Strength Index (RSI) on the 14-day chart is 63.14, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 4.03, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 11.96%. Stochastics %K at 83.74% indicates the stock is a selling.
How much short interest is there in Resmed Inc?
A steep rise in short interest was recorded in Resmed Inc stocks on 2025-05-15, growing by 1.83 million shares to a total of 10.93 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 9.11 million shares. There was a rise of 16.71%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 13, 2024 when Stifel began covering the stock and recommended ‘”a Hold”‘ rating along with a $250 price target.
